.AstraZeneca has actually utilized artificial intelligence to design a special biomarker for its Dai...
.AstraZeneca managers say they are actually "certainly not anxious" that the breakdown of tozorakima...
.Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, shooting...
.After uncovering plans to attack the united state social markets less than a month ago, Zenas Bioph...
.Psyence Biomedical is actually paying for $500,000 in portions to obtain fellow psilocybin-based bi...
.5 months after validating Electrical Therapies' Pivya as the 1st brand new therapy for uncomplicate...
.Eli Lilly has actually vaulted into an AI-enabled medication invention offer, partnering along with...
.Lykos CEO and also creator Amy Emerson is walking out, with principal functioning police officer Mi...
.Novartis levels a brand new frontier in its partnership along with Voyager Therapies, paying $15 th...
.On the heels of an FDA turndown for its own chief rivalrous Novo Nordisk, Eli Lilly is actually pic...
.Only a couple of months after dosing the 1st person in a phase 2 test for freshly diagnosed gliobla...
.Eli Lilly's hunt for obesity intendeds has led it to the dark genome. The Big Pharma has actually a...
.Collection Biosciences is actually proceeding up. The cell treatment firm has added on $325 thousan...
.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...
.Aelis Farma's hopes of securing a simple, positive choice on a $100 million choice payment have act...
.ProKidney has stopped one of a set of stage 3 tests for its own cell treatment for renal condition ...
.Vaxcyte revealed what experts named "spectacular" stage 1/2 information for its 31-valent pneumococ...
.Recursion has actually stumbled by means of an early exam of its own tech-enabled approach to medic...
.Call it an instance of good chemical make up: Acepodia, a biotech based on Nobel Prize-winning scie...
.Praxis Accuracy Medicines has actually scored one more midphase win in epilepsy this year, with its...